restrictive lung disease

SAN DIEGO, September 1, 2026 aTyr Pharma, Inc. expects to receive a response from the U.S. Food and Drug...

SAN DIEGO, May 11, 2026 aTyr Pharma announced a major regulatory and clinical development update for its lead investigational...